FDA Approves New Thyroid Cancer Treatment
About nine out of 10 U.S. thyroid cancer diagnoses are differentiated thyroid cancers; the FDA approval provides a new...
About nine out of 10 U.S. thyroid cancer diagnoses are differentiated thyroid cancers; the FDA approval provides a new...
Ibrutinib – a drug that targets the molecule that fuels the growth of B cells in Waldenstrom macroglobulinemia and...
The FDA recently approved new therapeutics for acute lymphoblastic leukemia, metastatic melanoma, and advanced ovarian cancer. In December 2014,...
The FDA recently approved a new HPV vaccine that could prevent up to 90 percent of cervical cancers in...